Multiple Myeloma Clinical Trials in Pamplona

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
J
Active, not recruiting
  • Multiple Myeloma
  • Dara SC
  • Dara IV
  • Boston, Massachusetts
  • +146 more
2021-12-02
Dec 2, 2021
J
Active, not recruiting
  • Multiple Myeloma
  • Daratumumab Subcutaneous (SC) Administration
  • Recombinant Human Hyaluronidase [rHuPH20]) SC Administration
  • Atlanta, Georgia
  • +11 more
2021-12-02
Dec 2, 2021
J
Recruiting
  • Multiple Myeloma
  • Carfilzomib 20 mg/m^2
  • +4 more
  • Gilbert, Arizona
  • +113 more
2021-12-02
Dec 2, 2021
J
Active, not recruiting
  • Multiple Myeloma
  • Southington, Connecticut
  • +63 more
2021-12-02
Dec 2, 2021
P
Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +4 more
  • Sevilla, Andalucia, Spain
  • +17 more
2021-11-19
Nov 19, 2021
O
Active, not recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +104 more
2021-11-17
Nov 17, 2021
C
Recruiting
  • Multiple Myeloma
  • bb2121
  • +8 more
  • Birmingham, Alabama
  • +50 more
2021-11-10
Nov 10, 2021
J
Recruiting
  • Multiple Myeloma
  • Edmonton, Alberta, Canada
  • +12 more
2021-11-04
Nov 4, 2021
C
Recruiting
  • Multiple Myeloma
  • CTX120
  • Chicago, Illinois
  • +9 more
2021-10-07
Oct 7, 2021